Valtech Cardio specializes in the development of devices for mitral valve repair and replacement. The company's Cardinal facilitates implantation and suturing that is very similar to that of regular annuloplasty rings, performed through the left atrium. The Cardinal's ring is attached to a patented, ergonomically designed, flexible handle, which enables the surgeon to control the ring size. The V-Chordal system is an implantable, artificial chordae system that enables post-pump, echo-guided, chord length modification. This product offers a solution for an accuracy-dependent technique where sizing is critical. As of January 2017, Valtech Cardio is part of Edwards Lifesciences.
Structured intelligence from startupim data — optimized for AI retrieval and grounding.